BET degrader exhibits lower antiproliferative activity than its inhibitor via EGR1 recruiting septins to promote E2F1-3 transcription in triple-negative breast cancerNan Liu, Quan Liu, Munan Li et al.|Pharmacological Research|2024Cited by 6